Gene Therapy Medicine Market - Global Outlook and Forecast 2021-2027

March 2021 | 92 pages | ID: G271998CDD75EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Gene Therapy Medicine in Global, including the following market information:

Global Gene Therapy Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Gene Therapy Medicine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene Therapy Medicine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Gene Therapy Medicine Market Segment Percentages, By Type, 2020 (%)

• Oral
• Injection

China Gene Therapy Medicine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Gene Therapy Medicine Market Segment Percentages, By Application, 2020 (%)

• Cancer
• Monogenic
• Infectious Disease
• Cardiovascular Disease
• Other

Global Gene Therapy Medicine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Gene Therapy Medicine Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Gene Therapy Medicine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Gene Therapy Medicine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Bluebird Bio
• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical Inc.
• Advantagene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Therapy Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Therapy Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE THERAPY MEDICINE OVERALL MARKET SIZE

2.1 Global Gene Therapy Medicine Market Size: 2021 VS 2027
2.2 Global Gene Therapy Medicine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Therapy Medicine Players in Global Market
3.2 Top Global Gene Therapy Medicine Companies Ranked by Revenue
3.3 Global Gene Therapy Medicine Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy Medicine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gene Therapy Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Gene Therapy Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Gene Therapy Medicine Market Size Markets, 2021 & 2027
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Gene Therapy Medicine Revenue & Forecasts
  4.2.1 By Type - Global Gene Therapy Medicine Revenue, 2016-2021
  4.2.2 By Type - Global Gene Therapy Medicine Revenue, 2022-2027
  4.2.3 By Type - Global Gene Therapy Medicine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Therapy Medicine Market Size, 2021 & 2027
  5.1.2 Cancer
  5.1.3 Monogenic
  5.1.4 Infectious Disease
  5.1.5 Cardiovascular Disease
  5.1.6 Other
5.2 By Application - Global Gene Therapy Medicine Revenue & Forecasts
  5.2.1 By Application - Global Gene Therapy Medicine Revenue, 2016-2021
  5.2.2 By Application - Global Gene Therapy Medicine Revenue, 2022-2027
  5.2.3 By Application - Global Gene Therapy Medicine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Gene Therapy Medicine Market Size, 2021 & 2027
6.2 By Region - Global Gene Therapy Medicine Revenue & Forecasts
  6.2.1 By Region - Global Gene Therapy Medicine Revenue, 2016-2021
  6.2.2 By Region - Global Gene Therapy Medicine Revenue, 2022-2027
  6.2.3 By Region - Global Gene Therapy Medicine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Gene Therapy Medicine Revenue, 2016-2027
  6.3.2 US Gene Therapy Medicine Market Size, 2016-2027
  6.3.3 Canada Gene Therapy Medicine Market Size, 2016-2027
  6.3.4 Mexico Gene Therapy Medicine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Gene Therapy Medicine Revenue, 2016-2027
  6.4.2 Germany Gene Therapy Medicine Market Size, 2016-2027
  6.4.3 France Gene Therapy Medicine Market Size, 2016-2027
  6.4.4 U.K. Gene Therapy Medicine Market Size, 2016-2027
  6.4.5 Italy Gene Therapy Medicine Market Size, 2016-2027
  6.4.6 Russia Gene Therapy Medicine Market Size, 2016-2027
  6.4.7 Nordic Countries Gene Therapy Medicine Market Size, 2016-2027
  6.4.8 Benelux Gene Therapy Medicine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Gene Therapy Medicine Revenue, 2016-2027
  6.5.2 China Gene Therapy Medicine Market Size, 2016-2027
  6.5.3 Japan Gene Therapy Medicine Market Size, 2016-2027
  6.5.4 South Korea Gene Therapy Medicine Market Size, 2016-2027
  6.5.5 Southeast Asia Gene Therapy Medicine Market Size, 2016-2027
  6.5.6 India Gene Therapy Medicine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Gene Therapy Medicine Revenue, 2016-2027
  6.6.2 Brazil Gene Therapy Medicine Market Size, 2016-2027
  6.6.3 Argentina Gene Therapy Medicine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Therapy Medicine Revenue, 2016-2027
  6.7.2 Turkey Gene Therapy Medicine Market Size, 2016-2027
  6.7.3 Israel Gene Therapy Medicine Market Size, 2016-2027
  6.7.4 Saudi Arabia Gene Therapy Medicine Market Size, 2016-2027
  6.7.5 UAE Gene Therapy Medicine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Bluebird Bio
  7.1.1 Bluebird Bio Corporate Summary
  7.1.2 Bluebird Bio Business Overview
  7.1.3 Bluebird Bio Gene Therapy Medicine Major Product Offerings
  7.1.4 Bluebird Bio Gene Therapy Medicine Revenue in Global (2016-2021)
  7.1.5 Bluebird Bio Key News
7.2 Sangamo
  7.2.1 Sangamo Corporate Summary
  7.2.2 Sangamo Business Overview
  7.2.3 Sangamo Gene Therapy Medicine Major Product Offerings
  7.2.4 Sangamo Gene Therapy Medicine Revenue in Global (2016-2021)
  7.2.5 Sangamo Key News
7.3 Spark Therapeutics
  7.3.1 Spark Therapeutics Corporate Summary
  7.3.2 Spark Therapeutics Business Overview
  7.3.3 Spark Therapeutics Gene Therapy Medicine Major Product Offerings
  7.3.4 Spark Therapeutics Gene Therapy Medicine Revenue in Global (2016-2021)
  7.3.5 Spark Therapeutics Key News
7.4 Dimension Therapeutics
  7.4.1 Dimension Therapeutics Corporate Summary
  7.4.2 Dimension Therapeutics Business Overview
  7.4.3 Dimension Therapeutics Gene Therapy Medicine Major Product Offerings
  7.4.4 Dimension Therapeutics Gene Therapy Medicine Revenue in Global (2016-2021)
  7.4.5 Dimension Therapeutics Key News
7.5 Avalanche Bio
  7.5.1 Avalanche Bio Corporate Summary
  7.5.2 Avalanche Bio Business Overview
  7.5.3 Avalanche Bio Gene Therapy Medicine Major Product Offerings
  7.5.4 Avalanche Bio Gene Therapy Medicine Revenue in Global (2016-2021)
  7.5.5 Avalanche Bio Key News
7.6 Celladon
  7.6.1 Celladon Corporate Summary
  7.6.2 Celladon Business Overview
  7.6.3 Celladon Gene Therapy Medicine Major Product Offerings
  7.6.4 Celladon Gene Therapy Medicine Revenue in Global (2016-2021)
  7.6.5 Celladon Key News
7.7 Vical Inc.
  7.7.1 Vical Inc. Corporate Summary
  7.7.2 Vical Inc. Business Overview
  7.7.3 Vical Inc. Gene Therapy Medicine Major Product Offerings
  7.4.4 Vical Inc. Gene Therapy Medicine Revenue in Global (2016-2021)
  7.7.5 Vical Inc. Key News
7.8 Advantagene
  7.8.1 Advantagene Corporate Summary
  7.8.2 Advantagene Business Overview
  7.8.3 Advantagene Gene Therapy Medicine Major Product Offerings
  7.8.4 Advantagene Gene Therapy Medicine Revenue in Global (2016-2021)
  7.8.5 Advantagene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy Medicine Market Opportunities & Trends in Global Market
Table 2. Gene Therapy Medicine Market Drivers in Global Market
Table 3. Gene Therapy Medicine Market Restraints in Global Market
Table 4. Key Players of Gene Therapy Medicine in Global Market
Table 5. Top Gene Therapy Medicine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gene Therapy Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gene Therapy Medicine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gene Therapy Medicine Product Type
Table 9. List of Global Tier 1 Gene Therapy Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Gene Therapy Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gene Therapy Medicine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gene Therapy Medicine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Gene Therapy Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gene Therapy Medicine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gene Therapy Medicine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Gene Therapy Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gene Therapy Medicine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gene Therapy Medicine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gene Therapy Medicine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gene Therapy Medicine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gene Therapy Medicine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gene Therapy Medicine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gene Therapy Medicine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gene Therapy Medicine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gene Therapy Medicine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gene Therapy Medicine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gene Therapy Medicine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gene Therapy Medicine Revenue, (US$, Mn), 2022-2027
Table 30. Bluebird Bio Corporate Summary
Table 31. Bluebird Bio Gene Therapy Medicine Product Offerings
Table 32. Bluebird Bio Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 33. Sangamo Corporate Summary
Table 34. Sangamo Gene Therapy Medicine Product Offerings
Table 35. Sangamo Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 36. Spark Therapeutics Corporate Summary
Table 37. Spark Therapeutics Gene Therapy Medicine Product Offerings
Table 38. Spark Therapeutics Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 39. Dimension Therapeutics Corporate Summary
Table 40. Dimension Therapeutics Gene Therapy Medicine Product Offerings
Table 41. Dimension Therapeutics Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 42. Avalanche Bio Corporate Summary
Table 43. Avalanche Bio Gene Therapy Medicine Product Offerings
Table 44. Avalanche Bio Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 45. Celladon Corporate Summary
Table 46. Celladon Gene Therapy Medicine Product Offerings
Table 47. Celladon Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 48. Vical Inc. Corporate Summary
Table 49. Vical Inc. Gene Therapy Medicine Product Offerings
Table 50. Vical Inc. Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)
Table 51. Advantagene Corporate Summary
Table 52. Advantagene Gene Therapy Medicine Product Offerings
Table 53. Advantagene Gene Therapy Medicine Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy Medicine Segment by Type
Figure 2. Gene Therapy Medicine Segment by Application
Figure 3. Global Gene Therapy Medicine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gene Therapy Medicine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gene Therapy Medicine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy Medicine Revenue in 2020
Figure 8. By Type - Global Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 12. US Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 16. Germany Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 17. France Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 24. China Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 28. India Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 30. Brazil Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gene Therapy Medicine Revenue Market Share, 2016-2027
Figure 33. Turkey Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gene Therapy Medicine Revenue, (US$, Mn), 2016-2027
Figure 37. Bluebird Bio Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Sangamo Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Spark Therapeutics Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Dimension Therapeutics Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Avalanche Bio Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Celladon Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Vical Inc. Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Advantagene Gene Therapy Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)